|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date31 Oct 2003 |
|
MechanismSerotonin reuptake inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.- |
First Approval Date01 Jan 1990 |
|
MechanismL-type calcium channel blockers |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.GB |
First Approval Date01 Mar 1989 |
100 Clinical Results associated with Pfizer Global Manufacturing China
0 Patents (Medical) associated with Pfizer Global Manufacturing China
100 Deals associated with Pfizer Global Manufacturing China
100 Translational Medicine associated with Pfizer Global Manufacturing China